Data Integrity

Securing the integrity of your electronic data and records is critical for safeguarding patient safety

Data Integrity Services

Signal management icon

Data Integrity Risk Assessments

We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA,...

Read More

Data Integrity Risk Assessments

We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Read Less
Safety systems icon

Policies & Procedures Framework

We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.

Policies & Procedures Framework

We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.

Read Less
Global literature review icon

Essential Training for Your Organization

Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.

Essential Training for Your Organization

Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.

Read Less
Computer System Validation icon

Data Governance Programs

We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature. 

Data Governance Programs

We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature. 

Read Less
Submissions icon

Standard Compliant Documentation, Tailored for You

We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your...

Read More

Standard Compliant Documentation, Tailored for You

We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization. 

Read Less
Compliance

ALCOA Principles Applied

We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA,...

Read More

ALCOA Principles Applied

We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Read Less

Data Integrity Risk Assessments

Everyone has heard the acronym "ALCOA", but our experts have experience assessing real-life situations vs. the principles of ALCOA to identify data integrity risks.

The purpose of a data integrity risk assessment is to provide you with the information you need to mitigate data integrity risks before your organization has a serious data integrity issue.

Radiofilum Pharmaceutical’s data integrity consultants follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.

Business worker with virtual attendees in conference room
Hands gesturing around a table with various charts and graphs

Here are the steps we take:

  • Meet to discuss your industry, products, and markets to determine the appropriate regulatory guidelines and any specific areas of concern, e.g., from CAPAs or past audits.
  • Tailor our standard assessment checklists to place the emphasis on the areas of highest risk.
  • Conduct the data integrity risk assessment – policies and procedures first, then specific systems and processes. The assessments include demonstrations of system functionality, review of policies and procedures, interviews with subject matter experts, and review of validation documentation.
  • Provide a Data Integrity Risk Assessment report identifying the areas of data integrity risk. Each risk is categorized as ‘critical’, ‘major’, or ‘minor’ to aid in prioritization of remediation activities.
  • Provide a Report of Recommended Actions for closure of each data integrity risk.
  • Facilitate follow-up meetings to ensure that the risks and recommendations are understood.

Data Integrity Framework of Policies & Procedures

A robust suite of Policies, Procedures, Work Instructions, and Templates provides the framework to ensure that data integrity is “built-in” from the start. Radiofilum Pharmaceutical ’s experienced data integrity consultants can have a QMS framework ready in a few weeks.

Here are the steps we take:

  • Meet to discuss what makes your organization unique, e.g.,
    • Industry-specific regulations, e.g., AOPO, CAP, COLA
    • Organization structure, roles, and responsibilities
    • Computer systems and tools already in use
  • Tailor Radiofilum Pharmaceutical ’s standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization.
  • Solicit feedback on the preliminary suite of documents and make adaptations before finalizing the Policies, Procedures, Work Instructions, and Templates.
  • Develop a Quality Manual to summarize the Policy and Procedure framework and provide an overview for employees, auditors, and inspectors.
Hand holding pen between fingers typing on laptop and using tablet device
Man using mobile phone tablet and laptop next to stethoscope and spiral notebook

Data Integrity Training

Delivering the right level of training at the right time is essential for embedding the principles of data integrity into company culture.

Radiofilum Pharmaceutical has a catalog of Data Integrity training courses that can be provided ‘as is’ or tailored to include examples from your daily operations.

  • Short training courses on Data Integrity Principles, suitable for Data Integrity program implementation and annual refresher training
  • Longer training courses on advanced Data Integrity topics such as:
    • ALCOA in Practice
    • Data Integrity Roles & Responsibilities
    • Data Governance Models
    • Digital Signatures
    • Computer System Validation

Data Governance Programs

A Data Governance program is more than simply determining who ‘owns’ the data.  It’s a program to monitor data integrity practices in real-time and ensure that they continue to mature.

Radiofilum Pharmaceutical’s data integrity consultants will guide you through the steps of implementing a Data Integrity Program that includes:

  • A structured program with defined roles and responsibilities for both leaders and subject matter experts
  • Processes for real-time monitoring of data integrity health through ongoing review of internal audit findings, metrics, and incident reports
  • Processes for prioritizing and initiating course corrections to ensure that issues are not repeated, and data integrity health metrics continue to improve
  • Standard process for building a roadmap to improve the organization’s Data Integrity program through strategic investments and targeted process improvements
Medical professionals business professionals working at a conference table
Validation Center Logo

Data Integrity Training & Resources

Access essential training and resources for computer system validation, compliance, and data integrity at Validation Center, Radiofilum Pharmaceutical knowledge center and resource.

Attend free webinars, enroll in online and in-person classes in the US and Europe, and download valuable templates and standard operating procedures. Validation Center offers everything you need for CSV and software quality assurance.

Meet our Data Integrity Experts

  • Deb Bartel Bio Photo

    Deb Bartel

    Vice President of Quality Assurance

  • Bob Verhoeff Bio Photo

    Bob Verhoeff

    Associate Director, Computer System Validation & Data Integrity

  • Rodrigo Perez Bio Photo

    Rodrigo Perez

    Associate Director, Computer System Validation & Data Integrity

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow

Customized Strategy. Globally Scaled Solutions

Radiofilum Pharmaceutical helps clients mitigate data integrity risks and ensure compliance with FDA, EMA, MHRA, and other agency standards.